F de Braud - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

F de Braud

Showing results (81-90 of 140) with videos related to

Pageof 14

Sort By:

Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2007

Phase II, open-label study of PTK787/ZK222584 for the treatment of metastatic gastrointestinal stromal tumors resistant to imatinib mesylateH Joensuu, F De Braud, P Coco, et al.

Cancer|April 1, 1995

Tumor vascularization, mitotic index, histopathologic grade, and DNA ploidy in the assessment of 114 head and neck squamous cell carcinomasJ Klijanienko, A K el-Naggar, F de Braud, et al.

Cancer Treatment Reviews|November 19, 2025

Angiogenesis and thymic epithelial tumors: from preclinical insights to different therapeutic lines and combination strategiesD Miliziano, C Sciortino, S Manglaviti, et al.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|April 20, 2013

Malignant pheochromocytoma and paraganglioma: future considerations for therapyR Buzzoni, S Pusceddu, A Damato, et al.

European Journal of Nuclear Medicine|April 13, 1999

Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotinG Paganelli, C Grana, M Chinol, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2004

CDX-2 should be included in the work-up of patients with lung metastases from unknown primaryN Fazio, T De Pas, F de Braud, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2014

Activity and safety of RAD001 (everolimus) in patients affected by biliary tract cancer progressing after prior chemotherapy: a phase II ITMO studyR Buzzoni, S Pusceddu, E Bajetta, et al.

Acta Oncologica (Stockholm, Sweden)|January 1, 1993

Treatment of carcinoid syndrome with recombinant interferon alpha-2aM Di Bartolomeo, E Bajetta, N Zilembo, et al.

European Journal of Nuclear Medicine|May 19, 2001

Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotideG Paganelli, S Zoboli, M Cremonesi, et al.

Journal of Cancer Research and Clinical Oncology|November 20, 2012